
INTRODUCTION: Preterm delivery is the leading cause of perinatal mortality and long-term neonatal morbidity in the United States, and rates are rising. Research has shown that COVID-19 infection may increase the possibility of preterm delivery. However, these studies disproportionately focus on third trimester and iatrogenic cases, often overlooking risk across the entire pregnancy or without adjusting for prior preterm delivery and sociodemographic factors. To address these gaps, the authors investigated the association between COVID-19 at any point in pregnancy and preterm delivery while exploring other predictors of preterm delivery. METHODS: tests, the authors explored associations between preterm delivery and other sociodemographic and clinical characteristics. Data were abstracted from electronic medical records. RESULTS: Of 14,250 participants, 994 (7%) experienced COVID-19 infection during pregnancy. Overall, 1313 (9%) had preterm delivery. In univariate logistic regression analyses, those with COVID-19 were more likely to be < 35 years old, Hispanic or Black, non-English-speaking, obese, and multiparous. COVID-19 infection during pregnancy was associated with increased odds of preterm delivery in the authors' unadjusted model but not in the multivariable adjusted model. Being ≥ 35 years old, Hispanic, Black, nulliparous, hypertensive, immunocompromised, or having a prior preterm delivery or gestational or chronic diabetes were significantly associated with higher odds of preterm delivery in the authors' multivariable model. CONCLUSION: COVID-19 infection throughout pregnancy was not associated with increased odds of preterm delivery. Racial disparities and other key covariates like history of preterm delivery may confound the reported increase in preterm delivery.
Introduction The US health care system imposes a heavy cost burden on Americans, contributing to high medical expenses and growing medical debt. Teaching medical trainees the importance of high-value care has been one strategy to combat this. The authors have introduced a cost awareness curriculum to first-year medical students and surveyed them on their knowledge and attitudes toward cost-conscious care before and after this intervention. Methods This repeated cross-sectional study used an anonymous, online pre-post-survey sent to first-year medical students in July and August of 2023 and 2024. Students were surveyed before and after out-of-pocket costs of commonly ordered items were displayed in preclinical lecture slides. Primary outcomes included changes in knowledge and attitude scores based on cost-estimate accuracy and agreement with cost-conscious statements. Pre-post groups were compared using χ 2 and Wilcoxon rank-sum tests. Results A total of 71 of 145 (49%) first-year medical students completed the presurvey, and 75 (51%) completed the postsurvey. On average, respondents correctly estimated the costs of 2 out of 9 commonly ordered items. There was high baseline support for cost-conscious care, and there was no difference in either attitudes or cost knowledge after exposure to the curriculum. Discussion First-year medical students supported cost-conscious care even without prior exposure to the concept. Despite ease of curriculum implementation, passive cost displays were insufficient to improve knowledge or change attitudes toward cost-conscious care. Conclusion Future studies could evaluate more substantial curricular changes such as case-based learning to assess whether they are more likely to impact cost awareness of medical trainees.
The authors have reported a case of a male patient in his 70s with end-stage renal disease on peritoneal dialysis and sevelamer use for hyperphosphatemia. The patient's hospital course was complicated by pulseless electrical activity cardiac arrest, infective endocarditis, and bacteremia. During the hospital course, the patient developed 2 episodes of large-volume bloody stools accompanied by hypotension. Colonoscopy was notable for ulcerated and pseudomembrane-covered mucosa in the rectum. Histopathology showed ulcerated colonic mucosa containing "scale- like" foreign crystals, consistent with sevelamer resin. Gastrointestinal bleeding secondary to sevelamer use has rarely been reported, with only 36 cases documented globally as of 2024. The cardiac arrest and hemodynamic instability may have contributed to mucosal vulnerability in the setting of sevelamer exposure. To the knowledge of the authors, this is the first reported case of sevelamer-induced gastrointestinal injury in a patient with recent cardiac arrest. No additional episodes of bleeding were observed after discontinuation of sevelamer.